Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.74%
1,094.84
+18.71
+1.74%
—1,076.131,079.891,100.771,079.89——
SIXC
Communications
SIXC
Communications
SIXC
-0.42%
604.21
-2.53
-0.42%
—606.74606.74607.90602.03——
SIXE
Energy
SIXE
Energy
SIXE
+0.07%
1,249.71
+0.89
+0.07%
—1,248.821,246.371,256.421,239.08——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.86%
1,739.26
+14.90
+0.86%
—1,724.361,733.021,745.751,727.76——
SIXM
Financials
SIXM
Financials
SIXM
+0.01%
635.63
+0.040
+0.01%
—635.59635.08637.96633.31——
SIXR
Staples
SIXR
Staples
SIXR
+0.61%
848.32
+5.17
+0.61%
—843.15842.50852.77840.85——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.22%
216.76
+0.47
+0.22%
—216.29216.29217.30215.24——
SIXT
Technology
SIXT
Technology
SIXT
+2.20%
3,335.14
+71.73
+2.20%
—3,263.413,296.253,343.663,295.42——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.01%
939.34
+0.10
+0.01%
—939.24941.57948.11939.11——
SIXV
Health care
SIXV
Health care
SIXV
+0.38%
1,468.17
+5.61
+0.38%
—1,462.561,465.031,471.561,459.66——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.28%
2,387.09
+6.69
+0.28%
—2,380.402,394.922,412.132,386.82——
2197:HKG
Clover Biopharmaceuticals Ltd
HK$2.88
-0.35%
(-0.0100) 1D
May 6, 9:30:00 AM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2197...
Open
HK$2.88
High
HK$2.88
Low
HK$2.88
Mkt. cap
3.74B
Avg. vol.
5.63M
Volume
500.00
52-wk high
HK$3.20
52-wk low
HK$0.19
EPS
-HK$0.19
Shares outstanding
1.30B
No. of employees
257
News stories
From sources across the web
About Clover Biopharmaceuticals Ltd
CEO-
Employees257
Founded2007
Headquarters-
SectorBiotechnology
Websitecloverbiopharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.63M
1.63M
125.50K
125.50K
Cost of goods sold
-19.00K
-19.00K
119.00K
119.00K
Cost of revenue
-19.00K
-19.00K
119.00K
119.00K
Research and development expenses
41.62M
41.62M
49.54M
49.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.05M
17.05M
18.65M
18.65M
Operating expense
58.71M
58.71M
70.38M
70.38M
Total operating expenses
58.69M
58.69M
70.50M
70.50M
Operating income
-57.07M
-57.07M
-70.38M
-70.38M
Other non operating income
6.50M
6.50M
11.57M
11.57M
EBT including unusual items
-50.64M
-50.64M
-51.91M
-51.91M
EBT excluding unusual items
-48.97M
-48.97M
-51.71M
-51.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
40.50K
40.50K
2.19M
2.19M
Net income
-50.64M
-50.64M
-51.91M
-51.91M
Net profit margin
-3,112.17%
-3,112.17%
-41,363.35%
-41,363.35%
Earnings per share
-
-
-
-
Interest and investment income
2.24M
2.24M
925.50K
925.50K
Interest expense
-124.00K
-124.00K
-64.50K
-64.50K
Net interest expenses
2.12M
2.12M
861.00K
861.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-52.19M
-52.19M
-66.72M
-66.72M
Gain or loss from assets sale
6.50K
6.50K
-2.00K
-2.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer